Skip to main content
SpringerLink
Log in

Incidence and severity of ICANS following CAR-T therapy in patients previously receiving ifosfamide

  • Correspondence
  • Published:
Bone Marrow Transplantation Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Data availability

The datasets analyzed during the current study are available from the corresponding author on reasonable request.

References

  1. Ajithkumar T, Parkinson C, Shamshad F, Murray P. Ifosfamide encephalopathy. Clin Oncol (R Coll Radio). 2007;19:108–14. https://doi.org/10.1016/j.clon.2006.11.003

    Article  CAS  Google Scholar 

  2. Nicolao P, Giometto B. Neurological toxicity of ifosfamide. Oncology. 2003;65(Suppl 2):11–16. https://doi.org/10.1159/000073352

    Article  CAS  Google Scholar 

  3. Lee DW, Santomasso BD, Locke FL, Ghobadi A, Turtle CJ, Brundo JN, et al. ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells. Biol Blood Marrow Transpl. 2019;25:625–38. https://doi.org/10.1016/j.bbmt.2018.12.758

    Article  CAS  Google Scholar 

  4. Gust J, Hay KA, Hanafi LA, Li D, Myerson D, Gonzalez-Cuyar LF, et al. Endothelial activation and blood-brain barrier disruption in neurotoxicity after adoptive immunotherapy with CD19 CAR-T cells. Cancer Discov. 2017;7:1404–19. https://doi.org/10.1158/2159-8290.CD-17-0698

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacy, Vanderbilt University Medical Center, Nashville, TN, USA

    Hunter Sowell, Katie Gatwood & Matthew Perciavalle

Authors
  1. Hunter Sowell
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Katie Gatwood
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Matthew Perciavalle
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

HS was responsible for reviewing patient charts to identify pertinent information to be included in the case report, writing the original manuscript, editing the manuscript, and manuscript submission. KG and MP identified the patient cases to be included in the case report, provided feedback on the manuscript, and edited the manuscript.

Corresponding author

Correspondence to Hunter Sowell.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sowell, H., Gatwood, K. & Perciavalle, M. Incidence and severity of ICANS following CAR-T therapy in patients previously receiving ifosfamide. Bone Marrow Transplant 58, 219–221 (2023). https://doi.org/10.1038/s41409-022-01873-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41409-022-01873-6

  • Springer Nature Limited

Search

Navigation